Your browser doesn't support javascript.
loading
Distinct progression patterns across Parkinson disease clinical subtypes.
Myers, Peter S; Jackson, Joshua J; Clover, Amber K; Lessov-Schlaggar, Christina N; Foster, Erin R; Maiti, Baijayanta; Perlmutter, Joel S; Campbell, Meghan C.
Afiliação
  • Myers PS; Department of Neurology, Washington University School of Medicine, St. Louis, Missouri, USA.
  • Jackson JJ; Department of Psychological and Brain Sciences, Washington University in St. Louis, St. Louis, Missouri, USA.
  • Clover AK; Department of Neurology, Washington University School of Medicine, St. Louis, Missouri, USA.
  • Lessov-Schlaggar CN; Department of Psychiatry, Washington University School of Medicine, St. Louis, Missouri, USA.
  • Foster ER; Department of Neurology, Washington University School of Medicine, St. Louis, Missouri, USA.
  • Maiti B; Department of Psychiatry, Washington University School of Medicine, St. Louis, Missouri, USA.
  • Perlmutter JS; Program in Occupational Therapy, Washington University School of Medicine, St. Louis, Missouri, USA.
  • Campbell MC; Department of Neurology, Washington University School of Medicine, St. Louis, Missouri, USA.
Ann Clin Transl Neurol ; 8(8): 1695-1708, 2021 08.
Article em En | MEDLINE | ID: mdl-34310084
ABSTRACT

OBJECTIVE:

To examine specific symptom progression patterns and possible disease staging in Parkinson disease clinical subtypes.

METHODS:

We recently identified Parkinson disease clinical subtypes based on comprehensive behavioral evaluations, "Motor Only," "Psychiatric & Motor," and "Cognitive & Motor," which differed in dementia and mortality rates. Parkinson disease participants ("Motor Only" n = 61, "Psychiatric & Motor" n = 17, "Cognitive & Motor" n = 70) and controls (n = 55) completed longitudinal, comprehensive motor, cognitive, and psychiatric evaluations (average follow-up = 4.6 years). Hierarchical linear modeling examined group differences in symptom progression. A three-way interaction among time, group, and symptom duration (or baseline age, separately) was incorporated to examine disease stages.

RESULTS:

All three subtypes increased in motor dysfunction compared to controls. The "Motor Only" subtype did not show significant cognitive or psychiatric changes compared to the other two subtypes. The "Cognitive & Motor" subtype's cognitive dysfunction at baseline further declined compared to the other two subtypes, while also increasing in psychiatric symptoms. The "Psychiatric & Motor" subtype's elevated psychiatric symptoms at baseline remained steady or improved over time, with mild, steady decline in cognition. The pattern of behavioral changes and analyses for disease staging yielded no evidence for sequential disease stages.

INTERPRETATION:

Parkinson disease clinical subtypes progress in clear, temporally distinct patterns from one another, particularly in cognitive and psychiatric features. This highlights the importance of comprehensive clinical examinations as the order of symptom presentation impacts clinical prognosis.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Progressão da Doença / Discinesias / Disfunção Cognitiva Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Clin Transl Neurol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Progressão da Doença / Discinesias / Disfunção Cognitiva Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Clin Transl Neurol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos